Charles Brigden
Directeur Général chez Eliptica Ltd.
Profil
Mr. Charles Brigden is Senior Vice President & Head-Business Development at BTG Plc.
He received his MBA from Columbia Business School.
Postes actifs de Charles Brigden
| Sociétés | Poste | Début |
|---|---|---|
Eliptica Ltd.
 Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Directeur Général | 01/04/2022 |
Anciens postes connus de Charles Brigden
| Sociétés | Poste | Fin |
|---|---|---|
| BTG | Corporate Officer/Principal | - |
Formation de Charles Brigden
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Eliptica Ltd.
Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Commercial Services |
